Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin Huls

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Blood|July 18, 2015
Azacitidine in AML: a treatment option?Gerwin Huls
Blood|January 20, 2022
COPD makes CHIP less indeterminateGerwin Huls
Annals of Hematology|April 27, 2019
Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?Emanuele Ammatuna, Gerwin Huls
Blood|June 12, 2020
The long road: improving outcome in elderly "unfit" AML?Bob Löwenberg, Gerwin Huls
European Journal of Haematology|December 12, 2012
Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomideMariëlle M Beckers, Gerwin Huls
Blood|December 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemiaGerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Current Opinion in Immunology|June 14, 2011
Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects?Carolien M Woolthuis, Gerald de Haan, Gerwin Huls
Mycopathologia|October 14, 2006
Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factorCelalettin Ustun, Gerwin Huls, Marc Stewart, et al.
The Lancet. Haematology|March 31, 2019
10-day vs 5-day decitabine: equivalence cannot be concludedGerwin Huls, Stefan Suciu, Pierre Wijermans, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Blood|July 18, 2015
Azacitidine in AML: a treatment option?Gerwin Huls
Blood|January 20, 2022
COPD makes CHIP less indeterminateGerwin Huls
Annals of Hematology|April 27, 2019
Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?Emanuele Ammatuna, Gerwin Huls
Blood|June 12, 2020
The long road: improving outcome in elderly "unfit" AML?Bob Löwenberg, Gerwin Huls
European Journal of Haematology|December 12, 2012
Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomideMariëlle M Beckers, Gerwin Huls
Blood|December 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemiaGerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Current Opinion in Immunology|June 14, 2011
Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects?Carolien M Woolthuis, Gerald de Haan, Gerwin Huls
Mycopathologia|October 14, 2006
Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factorCelalettin Ustun, Gerwin Huls, Marc Stewart, et al.
The Lancet. Haematology|March 31, 2019
10-day vs 5-day decitabine: equivalence cannot be concludedGerwin Huls, Stefan Suciu, Pierre Wijermans, et al.
Pageof 17